Can hypothyroidism, elevated TSH, or levothyroxine therapy cause an elevated insulin level?

Can Hypothyroidism, Elevated TSH, or Levothyroxine Cause Elevated Insulin Levels?

Yes, hypothyroidism and elevated TSH are directly associated with elevated insulin levels and insulin resistance, while levothyroxine therapy itself does not cause hyperinsulinemia—in fact, it may worsen glycemic control through a different mechanism by increasing insulin requirements in diabetic patients.

Hypothyroidism and Elevated TSH Cause Hyperinsulinemia

The evidence consistently demonstrates that both overt and subclinical hypothyroidism are associated with elevated insulin levels and insulin resistance:

• Overt hypothyroidism shows significantly elevated fasting insulin levels (9.07±3.41 μU/ml vs 5.28±2.18 μU/ml in controls) and increased HOMA-IR scores (2.03±0.95 vs 1.05±0.45) 12

• Subclinical hypothyroidism (TSH 4.5-10 mIU/L with normal free T4) also demonstrates insulin resistance, with 36% prevalence compared to 21% in euthyroid controls 3

• TSH levels correlate positively with insulin resistance: Studies show moderate positive correlation between TSH and HOMA-IR (r=0.48, P=0.01) 2, and this relationship persists even when controlling for BMI and other factors 4

The mechanism involves thyroid hormone's role in glucose metabolism—hypothyroidism leads to defective insulin secretion, altered peripheral glucose disposal, and increased insulin resistance 1.

Levothyroxine Does NOT Directly Cause Hyperinsulinemia

The FDA label for levothyroxine clearly states a different concern: levothyroxine may worsen glycemic control in diabetic patients, requiring increased antidiabetic medications or insulin doses 55. This is not the same as causing elevated insulin levels.

Key distinctions:

• Levothyroxine improves insulin sensitivity when correcting hypothyroidism 6
• In type 1 diabetics with hypothyroidism, higher TSH (undertreated hypothyroidism) correlates with higher insulin requirements, while adequate thyroid replacement (lower TSH, higher FT4) reduces insulin needs 7
• The FDA warning about "worsening glycemic control" refers to increased metabolic rate and glucose turnover requiring more exogenous insulin in diabetics—not elevated endogenous insulin production 5

Clinical Algorithm

When evaluating elevated insulin levels:

1. Check thyroid function (TSH, free T4) if not recently done
2. If TSH >4.5 mIU/L: Hypothyroidism is a likely contributor to hyperinsulinemia and insulin resistance
3. If patient is on levothyroxine with normal TSH: The medication itself is not causing elevated insulin; look for other causes of insulin resistance
4. If patient is on levothyroxine with elevated TSH: Inadequate thyroid replacement may be contributing to insulin resistance

Important Caveats

• The relationship between thyroid dysfunction and insulin resistance is independent of BMI 24, so don't dismiss the connection in non-obese patients
• Subclinical hypothyroidism (TSH 4.5-10 mIU/L) may not warrant treatment solely for metabolic effects according to guidelines 8, but the insulin resistance association exists and increases cardiovascular risk 19
• In diabetic patients starting levothyroxine, monitor glucose closely as insulin/medication requirements will change 55

The bottom line: elevated TSH and hypothyroidism cause elevated insulin levels through insulin resistance, while levothyroxine therapy corrects this problem rather than causing it.